首页|氨磺必利与利培酮治疗首发精神分裂症的疗效对照研究

氨磺必利与利培酮治疗首发精神分裂症的疗效对照研究

Amisulpride and Risperidone Treatment First-episode Schizophrenia

扫码查看
目的:分析氨磺必利与利培酮治疗首发精神分裂症的疗效差异。方法选择74例首发精神分裂症患者为研究对象,分别给予氨磺必利及利培酮治疗,比较BPRS量表评分、不良反应发生率。结果观察组与对照组BPRS量表评分值均明显降低,组间比较无明显差异(P>0.05);观察组不良反应发生率(18.92%)明显低于对照组(P<0.05)。结论氨磺必利与利培酮均可有效治疗首发精神分裂症,氨磺必利不良反应较少,具有优良的治疗安全性。
Objective To analysis efficacy of amisulpride and risperidone treatment first -episode schizophrenia.Methods 74 patients with first -episode schizo-phrenia were given Amisulpride and risperidone therapy,BPRS score,adverse reaction were compared.Result BPRS rating scale values were significantly reduced,be-tween groups was no significant difference;observation group adverse reactions(18.92%) was obviously lower than the control group.Conclusion Amisulpride and risper-idone can be effective in the treatment of first-episode schizophrenia,Amisulpride low adverse reaction,good safety.

SchizophreniaAmisulprideRisperidone

李婕

展开 >

济宁市精神病防治院,山东 济宁 272051

精神分裂症 氨磺必利 利培酮

2014

中国保健营养(上旬刊)
全国卫生产业企业管理协会

中国保健营养(上旬刊)

ISSN:1004-7484
年,卷(期):2014.(1)
  • 1
  • 5